ArticlePharmaceutics2023

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects.

JungJin Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.